Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products. As of 2016, some of the major players operating in this market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US). |
January 2018 | $ 5650 |
|
Wearable Medical Devices Market by Device (Diagnostic (Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin, Rehabilitation)), Application (Sport, Fitness, RPM), Type (Smartwatch, Patch), Distribution Channel (Pharmacy, Online) - Global Forecast to 2022The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The wearable medical devices market is highly competitive with several big and small players. Prominent players in this market include Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). The other players operating in this market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar (Finland), Wor(l)d Global Network (US), Activeinsights (UK), VitalConnect (US), Xiaomi (China), Misfit (US), and Monica Healthcare (UK). |
January 2018 | $ 5650 |
|
Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2023The global ventilators market is projected to reach USD 1,261.9 Million by 2023 from USD 859.9 Million in 2018, at a CAGR of 8.0%. Rapid growth in the geriatric population, increasing incidence of preterm births, and rising number of ICU beds are the major factors driving the growth of the ventilators market. Moreover, the growing investments, favorable regulatory policies, and growth in the healthcare industry in emerging countries in the Asian region are expected to provide favorable growth opportunities for players operating in the ventilators market. The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland). |
January 2018 | $ 5650 |
|
Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US). |
January 2018 | $ 5650 |
|
Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia). |
January 2018 | $ 5650 |
|
Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (US), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada). |
January 2018 | $ 5650 |
|
Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Gastroenterology, Diabetes), End User (Hospital, Home Care) - Global Forecast to 2022The enteral feeding devices market is expected to reach USD 3.19 Billion by 2022 from USD 2.26 Billion in 2016, at a CAGR of 6.0% during the forecast period. The increasing prevalence of chronic diseases, rising geriatric population, rising incidence of preterm births, growing demand for enteral feeding devices in the home care sector, and the shift from parenteral to enteral nutrition are the major factors driving the growth of the enteral feeding devices market. The prominent players in the enteral feeding devices market are Fresenius Kabi (Germany), Halyard Health (US), Medtronic (Ireland), B. Braun (Germany), Abbott (US), C.R. Bard (US), Boston Scientific (US), Cook Medical (US), CONMED (US), Nestlé (Switzerland), Danone (France), Moog (US), Vygon (France), and Applied Medical Technology (US). |
January 2018 | $ 5650 |
|
Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022Global cancer/tumor profiling market is projected to reach USD 8.74 Billion in 2022 from USD 5.26 Billion in 2017 at CAGR of 10.7%. Major players operating in the cancer/tumor profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the cancer/tumor profiling market. |
January 2018 | $ 5650 |
|
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022The global market for clinical laboratory services is projected to reach $146.41 billion by 2022 from $113.44 billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others |
December 2017 | $ 5650 |
|
Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022The global amniocentesis needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. |
December 2017 | $ 5650 |
|
Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK). |
December 2017 | $ 5650 |
|
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US). |
December 2017 | $ 5650 |
|
Optometry/Eye Exam Equipment Market by Type (OCT, Fundus Cameras, Perimeters, Ophthalmoscope, Ultrasound, Autorefractor, Slit Lamp, Corneal Topography, Lensmeter, Chart Projectors, Wavefront Analyzer), End User (Hospital, Clinic) - Global Forecast to 2022The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France). |
December 2017 | $ 5650 |
|
EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User - Global Forecast to 2022The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US). |
December 2017 | $ 5650 |
|
Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), and Accessories (Powder, Paste)), End User (Home, Hospital) - Global Forecast to 2022The global ostomy care market is projected to reach USD 2.99 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 4.5% during the forecast period. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the ostomy market. The major players in the ostomy care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK). |
December 2017 | $ 6780 |
|
Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stents market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea). |
December 2017 | $ 5650 |
|
Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022The global endoscopy equipment market was valued at USD 24.32 Billion in 2016 and is projected to reach USD 34.82 Billion by 2022, at a CAGR of 6.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. The key players in the global endoscopy equipment market are Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm (Japan), Medtronic (Ireland), Hoya (Japan), CONMED (US), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), Cogentix Medical (US), and B. Braun (Germany). |
December 2017 | $ 7150 |
|
Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022The global interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices. Key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany). |
December 2017 | $ 5650 |
|
OTC Braces & Support Market by Product (Knee, Back, Spine, Hip, Ankle, Foot, Shoulder, Elbow, Hand), Application (Osteoarthritis, Preventive Care, Ligament Injury), Sales Channel (Pharmacies, Retailers, E-Commerce, Hospitals) - Global Forecasts to 2022The global OTC braces and supports market is projected to reach USD 1.42 Billion by 2022 from USD 1.10 Billion in 2017, at a CAGR of 5.2%. Factors such as growing prevalence of musculoskeletal disorders and diseases, rapid growth in the geriatric population, rising number of sports-related injuries, and growing adoption of e-commerce platforms for OTC orthopedic braces are driving the growth of the market. As of 2016, key players in this market are DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), and Bauerfeind AG (Germany). Other important players in this market include Otto Bock HealthCare (Germany), BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), and THUASNE Group (France), among others. |
December 2017 | $ 5650 |
|
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland). |
November 2017 | $ 5650 |
|
Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) - Global Forecast to 2022The blood warmer devices market is expected to reach USD 225.6 Million by 2022 from USD 138.7 Million in 2016 at a CAGR of 8.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players in the tissue diagnostics market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US). |
November 2017 | $ 5650 |
|
Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the lung stents market. The prominent players in the global lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK). |
November 2017 | $ 5650 |
|
Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022The global contrast media/contrast agents market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and growing number of public and private diagnostic centers. The prominent players in the global contrast media market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India). |
November 2017 | $ 5650 |
|
Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) - Global Forecast to 2022The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US). |
November 2017 | $ 5650 |
|
Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022The global urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. The growing incidence of urological cancer along with a rapidly aging population, technological advancements in urology devices, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany). |
November 2017 | $ 5650 |
|
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. The key players in the global blood collection market are BD (US), Medtronic (US), and Terumo (Japan). Some of the other players operating in this market are Haemonetics (US), Fresenius (Germany) Nipro Medical (US), Kawasumi Laboratories (Japan), F.L. Medical (Italy), Greiner Holding (Austria), and Grifols (Spain). |
November 2017 | $ 5650 |
|
Surgical Imaging Market by Technology (Image Intensifier C-arms, Flat Panel Detector C-arms (FPD C-arms)), Application (Orthopaedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries), and Region - Global Forecasts to 2022The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence. GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India). |
November 2017 | $ 5650 |
|
Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. The home healthcare market is highly competitive with the presence of several small and big players. Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland). |
November 2017 | $ 5650 |
|
Nerve Repair and Regeneration Market by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), - Global Forecast to 2022The nerve repair and regeneration market is expected to reach USD 10.59 Billion from USD 5.13 Billion in 2016, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, rising geriatric population, and technological advancements are contributing to the growth of this market. Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US). |
November 2017 | $ 5650 |
|
Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022The global tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 6.9%. The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US). |
November 2017 | $ 5650 |
|
Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market. Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US). |
November 2017 | $ 5650 |
|
US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices. |
November 2017 | $ 5650 |
|
Intravascular Temperature Management Market by Type (Warming, Cooling), Application (Perioperative, Post-operative, Acute Care), Medical Condition (Stroke, Cardiac Arrest, Traumatic Brain Injury (TBI), Myocardial Infarction) - Global Forecasts to 2022The global intravascular temperature management market is projected to reach USD 272.3 Million by 2022 from USD 219.8 Million in 2016, growing at a CAGR of 3.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Key players in the intravascular temperature management market include 3M (US), Smiths (UK), ZOLL Medical (US), The 37Company (Netherlands), Belmont Instrument (US), Biegler (Austria), Stihler Electronic (Germany), and BD company (US). |
November 2017 | $ 18000 |
|
Hearing Aids Market by Product (Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant), Types of Hearing Loss (Sensorineural, Conductive Hearing loss) & Patient (Adult, Pediatric) - Forecast to 2022The global hearing aids market is projected to reach USD 9.78 Billion by 2022 from USD 6.97 Billion in 2017, at a CAGR of 7.0%. Factors such as high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids are driving the global hearing aids market. The hearing aids market is dominated by big players such as Sonova (Switzerland), William Demant (Denmark), and GN Store Nord (Denmark) with the presence of several small players as well. Some of the players operating in this market include Cochlear (Australia), Starkey (US), Widex (Denmark), MED-EL (Austria), SeboTek Hearing Systems (US), Audina Hearing Instruments (US), RION (Japan), Horentek (Italy), Microson (Spain), and Arphi Electronics (India). |
November 2017 | $ 5650 |
|
Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022The global advanced wound care market is expected to reach USD 13.07 Billion by 2022 from USD 10.43 Billion in 2017, at a CAGR of 4.6%. The market growth is primarily driven by the rising incidence and prevalence of diabetes, growth in geriatric population, increasing prevalence of wound ulcers, technological advancements in advanced wound care products, increasing funding for wound care research, and growing awareness programs about wound management. The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences(US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK). |
November 2017 | $ 5650 |
|
Weight Loss and Weight Management Market by Equipment (Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass), Fitness (Treadmill, Elliptical, Stair Stepper)), Diet (Meal, Beverage, Supplement) and Weight Loss Services - Global Forecast to 2022The weight loss and weight management market is projected to reach USD 245.51 Billion by 2022 from USD 175.94 Billion in 2017, at a CAGR of 6.9%. Factors such as growing obesity rates, increasing number of bariatric surgeries, and increasing prevalence of lifestyle diseases are driving the global weight loss and weight management market. The weight loss and weight management market is highly competitive, with the presence of several small and large players. Some of the players operating in this market include Atkins Nutritionals (US), Herbalife (US), Nutrisystem (US), Ethicon (US), Covidien (US), Apollo Endosurgery (US), Brunswick (US), Amer Sports (Finland), Johnson Health Technology (Taiwan), Technogym (Italy), Weight Watchers (US), Jenny Craig (US), eDiets.com (US), VLCC Healthcare (India), Slimming World (UK), The Gold’s Gym (US), Duke Diet & Fitness Center (US), Equinox (US), Life Time Fitness (US), Fitness First Group (US), and Town Sports (US). |
October 2017 | $ 5650 |
|
Sterilization Services Market by Method (Steam, Ethylene Oxide, Gamma, E-beam), Type (Contract Sterilization Services, Validation Services), End User (Hospitals and Clinics, Food and Beverage, Pharmaceuticals), and Region - Global Forecast to 2022The global sterilization services market is expected to reach USD 3.31 Billion by 2022 from USD 2.39 Billion in 2017, at a CAGR of 6.7%. Factors driving market growth include the increasing incidence of HAIs, rising number of surgical procedures owing to the rapidly growing geriatric population, and increasing incidence of chronic disorders across the globe. The key players in the sterilization services market are STERIS (UK), Cantel Medical (US), Cretex Companies (US), E-BEAM Services (US), Medistri (Switzerland), Beta-Gamma-Service (Germany), Sterigenics International (US), COSMED Group (US), Life Science Outsourcing (US), Noxilizer (US), Centurion Medical Products (US), Johnson & Johnson (US), and Stryker (US). |
October 2017 | $ 5650 |
|
Wound Drainage/Surgical Drains Market by Product (Accessories, System (Open, Closed)), Type (Active, Passive), Application (Orthopedic, CVD, Thoracic, Obstetrics & Gynecology, Plastic surgery), End user (Hospitals, Clinics, ASC) - Global Forecast to 2022The surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.78 Billion in 2016, growing at a CAGR of 3.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The surgical drains market is highly competitive with the presence of several small and big players. Some of the players in the surgical drains market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (India), and Degania Silicone (Israel). |
October 2017 | $ 5650 |
|
Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2022The global endoscope reprocessing market has been valued at USD 1.34 Billion in 2016 and is expected to grow at a CAGR of 8.6% to reach to USD 2.15 Billion by 2022. Base year considered for the report is 2016 and the forecast period is 2017 to 2022. The various players in the endoscope reprocessing market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others. |
October 2017 | $ 5650 |
|
Hysteroscopy Instruments Market by Product (Forceps, Scissors, Hysteroscope (Rigid, Flexible), Resectoscope (Unipolar, Bipolar), Usability, Application (Diagnosis, Myomectomy, Polypectomy, EA), End User (Hospital, Clinic, ASC) - Global Forecast to 2022The hysteroscopy instruments market is expected to reach USD 1.89 Billion by 2022 from USD 1.30 Billion in 2017, at a CAGR of 7.8%. The growth of the market is attributed to the growth in female geriatric population and the rising incidence of gynecological diseases; increasing adoption of minimally invasive treatments; implementation of favorable government initiatives and the increasing adoption of office hysteroscopy. The hysteroscopy instruments market is highly competitive with the presence of several small and big players. Some of the players in the hysteroscopy instruments market include KARL STORZ (Germany), Olympus (Japan), Richard Wolf (Germany), Stryker (US), Hologic (US), Medtronic (Ireland), Ethicon (Scotland), B. Braun (Germany), Boston Scientific (US), MedGyn Products (US), CooperSurgical (US) , Cook Medical (US), Medicon (Germany), Maxer Medizintechnik (Germany), and Hospiline Equipments (India). |
October 2017 | $ 5650 |
|
Cancer Biomarkers Market by Type (Protein Biomarker, Genetic Biomarker), Cancer Type (Breast, Melanoma, Leukemia, Lung), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnosis, Prognostics, R&D) - Global Forecast to 2022Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids. They enhance cancer detection and facilitate high-speed noninvasive diagnosis using genomics and proteomics. The global cancer biomarkers market is accounted for USD 10.31 Billion in 2016 and is expected to grow at a CAGR of 12.2% to USD 20.48 Billion by 2022 during the forecast period. The major players in the cancer biomarkers profiling technology market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson (US), and Hologic (US). |
October 2017 | $ 7150 |
|
Sports Medicine Market by Application (Knee, Shoulder, Elbow), Product (Implants, Arthroscopy, Prosthetic, Orthobiologics, Braces, Compression Clothing, Physiotherapy (Thermal, Ultrasound), Bandages & Tapes) - Global Forecast to 2022Sports medicine pertains to the treatment and prevention of injuries resulting from sports and athletic activities. Sports injuries involve both bone and soft tissue injuries. The sports medicine market includes devices that are used for the prevention of sports injuries as well as for the cure, recovery, and rehabilitation of such injuries. The global sports medicine market is projected to reach USD 8.24 Billion by 2022 from USD 5.41 Billion in 2016, at a CAGR of 7.4% during the forecast period. Base year considered for the report is 2016. Forecast period considered for the report is 2017–2022. The key players in the global market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), CONMED (US), Zimmer Biomet. (US), Breg (US), DJO Global (US), Mueller Sports, (US), Wright Medical Group (US), Medtronic (Ireland), RTI Surgical (US), and Performance Health International (US). |
October 2017 | $ 5650 |
|
In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022The global in vitro fertilization market is projected to be valued at USD 465.2 Million in 2016 and is expected to grow at a CAGR of 10.9% from 2017 to reach to USD 847.8 Million by 2022. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden). |
October 2017 | $ 5650 |
|
Industrial Centrifuges Market by Type (Sediment, Decanter, Disc, Filter, Basket, Screen, Peeler, Pusher), Operation (Batch, Continuous), Design (Horizontal, Vertical), End User, and Region - Global Forecast to 2022The global industrial centrifuges market is projected to reach USD 11.06 Billion by 2022 from USD 8.69 Billion in 2017, at a CAGR of 4.9%. The increasing demand for centrifuges in process industries, rising need for wastewater management solutions, and technological advancements in centrifuge systems are the major factors driving the growth of this market. The market is highly fragmented with several big and small players. Prominent players in the market include Andritz, Alfa Laval, GEA Group, Mitsubishi Kakoki Kaisha, Thomas Broadbent, FLSmidth, Schlumberger, Hiller, Ferrum, TEMA, HEINKEL, Gruppo Pieralisi, SPX Flow, and HAUS Centrifuge Technologies. |
September 2017 | $ 5650 |
|
Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes. The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany). |
September 2017 | $ 5650 |
|
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical. |
September 2017 | $ 5650 |
|
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022The global liquid biopsy market is projected to be valued at USD 580.0 Million in 2016 and is expected to grow at a CAGR of 23.4% to reach to USD 2,047.9 Million by 2022. Base year considered for the report is 2016 and forecast period includes 2017–2022. Some of the key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D. The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US). |
September 2017 | $ 5650 |
|
Restorative Dentistry Market by Product (Restorative Material (Composite, Amalgam, Ceramic, Adhesive, Biomaterial), Prosthetic, Equipment (CAD/CAM, Handpiece, Articulator, Furnace) End User (Hospital, Dental Clinic, Laboratory) - Global Forecast to 2022The global restorative dentistry market is projected to reach USD 21.27 Billion by 2022 from USD 14.64 Billion in 2016, at a CAGR of 6.4% from 2017 to 2022. The major players in the restorative dentistry market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany). |
September 2017 | $ 5650 |
|
Orthopedic Braces and Supports Market by Product (Lower Extremity (Knee, Foot, Ankle, Back), Upper Extremity (Shoulder, Elbow, Wrist)), Application (Ligament Injury, Preventive Care, Osteoarthritis), End User (Hospitals, OTC) - Global Forecast to 2022The global orthopedic braces and supports market is projected to reach USD 4.93 Billion by 2022 from USD 3.76 Billion in 2017, at a CAGR of 5.6%. The major players in the market include DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), and Bauerfeind AG (Germany). Other key players in this market include Otto Bock HealthCare (Germany), BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), and THUASNE Group (France). |
September 2017 | $ 5650 |
|
Dental Lab Market by Material (Metal Ceramic, Ceramic (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, Scanner, Furnace, Articulators), Prosthetics (Bridge, Crown (Porcelain Fused to Metal, CAD CAM Ceramics), Dentures) - Global Forecast to 2022The global dental laboratories market is projected to reach USD 43.08 Billion by 2022 from USD 32.56 Billion in 2017, at a CAGR of 5.8% from 2017 to 2022. The major players in the dental laboratories market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), 3M Company (US), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Oy (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Zimmer Biomet Holdings, Inc. (US), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), and Shofu Inc. (Japan). |
September 2017 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
